Virchow Medical

The Virchow Medical Crow’s Nest Biopsy Catchment System improves core needle biopsy collection, tissue management, and access to targeted diagnostics.

Virchow Medical hires a **Chief Strategy Officer**, **Laboratory Manager**, and **Field Implementation Scientist** to bolster hospital adoption of its molecular specimen processing and precision oncology solutions. The new roles focus on streamlining clinical workflows and expanding the company’s precision diagnostics capabilities. These appointments reflect Virchow Medical’s push to deepen integration with hospital laboratories and oncology programs.

Nov 2026Yahoo FinanceNews article

Virchow Medical secures a **$4 million seed round** to improve **biopsy specimen management** and broaden access to **precision oncology diagnostics**. The company, co-founded by serial entrepreneur **Dr. Alexander Arrow**, focuses on optimizing tissue sample handling for better cancer treatment outcomes. This funding supports scaling infrastructure and partnerships to enhance precision medicine workflows.

May 2026EvoNexusNews article

Virchow raises seed funding to develop **Biopsy Catchment**, a technology for capturing and preserving tissue samples during procedures. The company also expands its **liquid specimen biorepository**, enabling long-term storage of blood and other fluid-based samples for cancer research. These tools aim to improve diagnostic accuracy and accelerate biomarker discovery in oncology.

Apr 2026Clinical Lab ProductsNews article

Virchow Medical, a La Jolla-based developer of biopsy technologies, secures $4 million in seed funding. The company, previously known as Corramedical, focuses on advancing biopsy techniques. This financing supports its growth and technology development in the medical diagnostics sector.

Mar 2026FinSMEsNews article